The Biology and Genetics of DAVID Syndrome

To understand DAVID syndrome, it helps to think of the NFKB2 gene as a set of instructions for a biological process that controls growth and defense. When this process is altered, it can send incorrect signals to two very different parts of the body: the brain’s pituitary gland and the immune system’s B cells ^[1].

The Role of NFKB2 and the p100 Protein

The NFKB2 gene’s main job is to create a protein called p100. In a healthy body, p100 acts like a piece of raw material that must be processed into a smaller, active form called p52 ^[1].

• The Normal Process: When the body needs to grow certain cells or fight an infection, it processes the large p100 protein into the active p52 version. This active p52 then moves into the center of the cell to turn on the genes needed for development and protection ^[1][2].
• The Mutation: In DAVID syndrome, there is usually a mutation in the C-terminal (the “tail end”) of the NFKB2 gene ^[3][4].

Because of this mutation, the processing can get stuck. The body ends up with too much of the “raw” p100 and not enough of the active p52. Current evidence suggests that the leftover p100 may act like a brake, blocking other important signals from getting through ^[1]. This disruption happens in what scientists call the noncanonical NF-κB signaling pathway ^[1].

Why One Mutation Can Affect Two Systems

It may seem strange that a single genetic variant affects both hormones and immunity, but both systems rely on this pathway during their early development.

1. The Pituitary Gland (Hormones): To create the cells that produce ACTH (the hormone that triggers cortisol), the developing pituitary gland needs proper signaling. Emerging research using “mini-organs” called organoids suggests that when NFKB2 is mutated, the pituitary may not develop enough corticotrophs—the specific cells that make ACTH ^[5]. This helps explain why children with this syndrome often have low cortisol ^[3].
2. The Immune System (Antibodies): B cells are the specialized white blood cells that make antibodies. To mature and learn how to fight specific germs, they also require this signaling ^[6]. When the pathway is disrupted, the B cells may struggle to differentiate into the mature cells (like memory B cells or plasmablasts) that produce high levels of antibodies ^[6][7]. The degree to which antibody production is impaired varies widely from patient to patient.

Inheritance: How it is Passed On

DAVID syndrome is an autosomal dominant condition. This means a person only needs one mutated copy of the NFKB2 gene (out of the two copies we all have) to potentially show symptoms ^[3].

• De Novo Mutations: In many cases, the mutation is de novo, meaning it is brand new in the child and was not inherited from either parent ^[4][1].
• Variable Penetrance: If a parent carries the pathogenic variant, each child generally has a 50% chance of inheriting it. However, penetrance and symptom severity are highly variable. Some people with the mutation may have severe symptoms, while others may have no obvious health problems at all (asymptomatic carriers) ^[6][8]. Testing of family members should always be directed by a genetic counselor ^[1].

How DAVID Differs from Standard CVID

You may hear doctors use the term Common Variable Immunodeficiency (CVID). While DAVID syndrome can look like CVID because of the low antibody levels, there are key biological differences:

• CVID is a broad “umbrella” term for many different immune failures. Most cases of CVID do not have a single known genetic cause ^[9].
• DAVID syndrome is a specific, single-gene cause of immune dysfunction that specifically involves the NFKB2 gene ^[1].
• Standard CVID does not typically include the pituitary hormone issues (like ACTH deficiency) that are the hallmark of DAVID syndrome ^[3][6].